The segregation, rotation of stock, and/or the transportation of raw materials, packaging materials, intermediates, bulk drugs, and/or finished products was inadequate. The premises were not designed, constructed, operated, and/or maintained to prevent contamination.
Inspection Record
Piramal Healthcare (Canada) Limited — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.
The creation, maintenance, processing, and/or review of laboratory data was inadequate.
The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.
The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2022-11-14. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
